Pharmaceutical Technology Pharmaceutical Import Profile — Dominican Republic (DGFT 2022–2026)

Name: Pharmaceutical Technology Pharmaceutical Import Records from India — 7 Products, $9.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmaceutical Technology — Pharmaceutical Importer Profile (2026) | 7 Products, $9.8M Trade | TransData Nexus

Pharmaceutical Technology

Pharmaceutical Importer · Dominican Republic · Cardiovascular Focus · $9.8M Total Trade · DGFT Verified

Pharmaceutical Technology is a pharmaceutical importer based in Dominican Republic with a total trade value of $9.8M across 7 products in 4 therapeutic categories. Based on 314 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmaceutical Technology sources from 58 verified Indian suppliers, with Cipla Limited accounting for 15.9% of imports.

Pharmaceutical Technology — Import Portfolio & Supplier Network

Pharmaceutical Technology import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmaceutical Technology?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$4.1M	400	15.9%
Mepro Pharmaceuticals Private Limited	$3.4M	224	13.2%
J B Chemicals And Pharmaceuticals Limited

What Formulations Does Pharmaceutical Technology Import?

Formulation	Value	Ships
Neomol inj10mg/ml100ml drp-ffs euro	$814.6K	21
Pamdol INJ 370MG 100ML(iopamidol)drp	$450.0K	9
Low molecular weight heparin	$349.7K	8
Nifedipine extended-release tablets 30MG	$316.6K	15
Pharmaceutical products: flomacor 500	$266.3K	11
Lustatin 20 MG tablets (rosuvastatin	$262.5K	12
Pentaglubine inj15ml(gadopentate dim	$235.8K	14
Fusibact-sterile (sodium fusidate	$201.7K	8
Sugest 200MG capsules (3x10"s)30c	$200.0K	4
Alcovera INJ 1000 MG dmrp	$198.0K	10
Pamdol INJ 370MG 50ML (iopamidol)drp	$181.0K	5
Heparin sodium injection 25000 IU/5ML(5000 IU/ML)	$164.8K	4
Sugest 200MG CAPS-30c(export)	$151.2K	5
Pamdol INJ 370MG 100mliopamidoldrp	$150.0K	3
Glipixor m 4/850 (glimepiride 4 MG +	$147.6K	4

Pharmaceutical Technology imports 1,269 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Heparin	Cardiovascular	$3.0M	64	0.8%	18
2	Enoxaparin	Cardiovascular	$2.3M	52	1.1%	11
3	Syringe	Medical Devices & Diagnostics	$1.7M	42	0.9%	15
4	Nifedipine	Cardiovascular	$1.2M	53	4.0%	4
5	Irbesartan	Cardiovascular	$982.7K	63	0.9%	19
6	Miconazole	Antifungals	$340.5K	15	1.7%	9
7	Glimepiride	Diabetes & Endocrine	$340.1K	25	0.4%	16

Pharmaceutical Technology imports 7 pharmaceutical products across 4 categories into Dominican Republic totaling $9.8M.

Pharmaceutical Technology — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmaceutical Technology is a pharmaceutical importer and buyer based in the Dominican Republic, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. The company operates from its headquarters at Calle Desiderio Valverde #103, Zona Universitaria, Santo Domingo, Dominican Republic. While specific details about its parent company are not publicly available, Pharmaceutical Technology plays a significant role in the Dominican Republic's pharmaceutical distribution network by sourcing a diverse range of pharmaceutical products to meet the country's healthcare needs.

2Distribution Network

Pharmaceutical Technology's distribution network encompasses the entire Dominican Republic, ensuring nationwide coverage. The company collaborates with various logistics partners to facilitate the efficient movement of pharmaceutical products from international suppliers to local healthcare providers. While specific warehouse locations are not publicly disclosed, the company's strategic partnerships and logistics capabilities enable it to maintain a robust supply chain, ensuring timely delivery of pharmaceutical products across the country.

3Industry Role

In the Dominican Republic's pharmaceutical supply chain, Pharmaceutical Technology functions primarily as a wholesaler and importer. By sourcing finished pharmaceutical formulations from international suppliers, the company bridges the gap between global manufacturers and local healthcare providers, ensuring the availability of essential medications in the domestic market. This role is crucial in maintaining a steady supply of pharmaceutical products, thereby supporting the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmaceutical Technology

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Pharmaceutical Technology's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 93% of its total import value. This concentration indicates a strategic focus on specific high-demand pharmaceutical products, which may enhance procurement efficiency and strengthen supplier relationships. However, such dependency on a limited product range could pose risks, including supply chain disruptions or market fluctuations affecting these key products. The company's extensive engagement with multiple Indian suppliers, as evidenced by 314 shipments from 58 unique suppliers, suggests a diversified sourcing approach that may mitigate some of these risks.

2Supply Chain Resilience

Pharmaceutical Technology's supply chain resilience is bolstered by its partnerships with a diverse array of Indian suppliers, encompassing 58 unique companies. This diversification reduces the impact of potential disruptions from any single supplier. The company's focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, allows for greater control over product quality and compliance with regulatory standards. While specific details about backup suppliers and shipping routes are not publicly available, the company's established relationships with reputable Indian manufacturers and its adherence to international shipping protocols suggest a robust and resilient supply chain capable of adapting to challenges.

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Dominican Republic

1Regulatory Authority & Framework

The Dominican Republic's pharmaceutical sector is regulated by the Ministry of Public Health and Social Assistance (MISPAS), specifically through the General Directorate of Medicines, Food, and Health Products (DIGEMAPS). This regulatory framework ensures that all pharmaceutical products meet the required standards for safety, efficacy, and quality before entering the market. Key legislation governing pharmaceutical imports includes the General Health Law No. 42-01 and Regulation No. 246-06 on Medicines, which outline the procedures for product registration, importation, and distribution.

2Import Licensing & GMP

Importers of pharmaceutical products into the Dominican Republic must obtain a Sanitary Register from MISPAS for each product they intend to import. This registration process requires submission of a complete technical dossier, including evidence of compliance with Good Manufacturing Practices (GMP). GMP certifications from recognized authorities, such as the World Health Organization (WHO) or the European Union (EU), are essential for the approval of pharmaceutical products. Additionally, importers must adhere to customs regulations, including registration with the General Directorate of Customs (DGA) and compliance with the Single Customs Declaration (DUA) system.

Pharmaceutical Technology — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Pharmaceutical Technology's product strategy focuses on high-demand therapeutic areas, particularly cardiovascular treatments and medical devices. The company's significant import values in products like Heparin, Enoxaparin, and Syringes indicate a strategic emphasis on these sectors. This focus aligns with the growing healthcare needs in the Dominican Republic, where cardiovascular diseases are prevalent. The importation of antifungals further suggests a comprehensive approach to addressing various health concerns within the country.

2Sourcing Profile

Pharmaceutical Technology's sourcing strategy is centered on finished pharmaceutical formulations, primarily from India. This approach allows the company to ensure product quality and compliance with regulatory standards, as Indian manufacturers often adhere to recognized GMP certifications. The company's diverse supplier base, with 58 unique Indian suppliers, indicates a strategic effort to mitigate risks associated with single-source dependency and to leverage competitive pricing and innovation from multiple sources.

3Market Positioning

Based on its product mix, Pharmaceutical Technology serves a broad segment of the Dominican Republic's pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's focus on essential medications and medical devices positions it as a key supplier to various healthcare providers, contributing to the overall accessibility and affordability of healthcare in the country.

Seller's Guide — How to Become a Supplier to Pharmaceutical Technology

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Pharmaceutical Technology, particularly in the cardiovascular and medical devices sectors. The company's concentrated sourcing pattern presents potential gaps that new suppliers can fill by offering high-quality products that meet the company's standards and align with market demand. Establishing partnerships with Pharmaceutical Technology could enhance the suppliers' presence in the Dominican market and contribute to the diversification of the company's product portfolio.

2Requirements & Qualifications

Indian exporters seeking to supply Pharmaceutical Technology and the Dominican Republic market must ensure their products are registered with MISPAS and comply with GMP standards recognized by international authorities such as WHO or the EU. Products must also meet labeling requirements in Spanish and adhere to local customs regulations. Additionally, obtaining a Sanitary Register from MISPAS is mandatory for each product intended for importation.

3How to Approach

Frequently Asked Questions — Pharmaceutical Technology

What products does Pharmaceutical Technology import from India?

Pharmaceutical Technology imports 7 pharmaceutical products across 4 categories. Top imports: Heparin ($3.0M), Enoxaparin ($2.3M), Syringe ($1.7M), Nifedipine ($1.2M), Irbesartan ($982.7K).

Who supplies pharmaceuticals to Pharmaceutical Technology from India?

Pharmaceutical Technology sources from 58 verified Indian suppliers. The primary supplier is Cipla Limited (15.9% of imports, $4.1M).

What is Pharmaceutical Technology's total pharmaceutical import value?

Pharmaceutical Technology's total pharmaceutical import value from India is $9.8M, based on 314 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmaceutical Technology focus on?

Pharmaceutical Technology imports across 4 categories. The largest: Cardiovascular (75.9%), Medical Devices & Diagnostics (17.1%), Antifungals (3.5%).

Get Full Pharmaceutical Technology Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.